Recently, several genome-wide association studies identified that increased expression of TROY was associated with susceptibility to nasopharyngeal carcinoma and lung malignancies [20, 21], suggesting a role of TROY in tumorigenesis. Here, TNFRSF19 is linked to nasopharyngeal carcinoma.